Gustavo Fenalti

Gustavo Fenalti has an extensive work experience in the field of structural biology and molecular design. Gustavo most recently held the position of Director of Structural Biology and Molecular Design at Replay Holdings since December 2021. Prior to that, they worked as a Principal Scientist at Bristol-Myers Squibb from December 2020 to December 2021. Gustavo also served as a Senior Scientist at Celgene from May 2017 to November 2020. Before that, they worked as a Scientist II / Biochemistry and Structural Biology at Celgene Corporation from December 2014 to April 2017. Gustavo Fenalti also worked briefly as a Staff Scientist at Takeda from April 2014 to December 2014. One of their notable positions was as a Research Associate at The Scripps Research Institute, where they worked from March 2009 to April 2014. Gustavo also gained research experience as a Post-Doctoral Research fellow at the Department of Biochemistry and Molecular Biology at Monash University from August 2007 to March 2009.

Gustavo Fenalti completed their education in two different institutions. From 1996 to 2002, they attended Pontificia Universidade Catolica do Rio Grande do Sul (PUC-RS), where they obtained a Bachelor of Pharmacy and a Clinical Laboratory Scientist Degree. During this time, their major focus of study revolved around Clinical Biochemistry, Immunology, Hematology, Parasitology, and Microbiology.

Subsequently, Gustavo pursued a higher degree at Monash University from 2003 to 2007. There, they obtained a PhD in Medical Science, specializing in Biochemistry and Structural Biology. Throughout their doctoral studies, their research primarily encompassed X-ray crystallography, Enzymology, Autoimmunity, and Protein Modeling.

Aside from their formal education, there is a certification mentioned in preventing workplace harassment. However, no specific details regarding the institution or the year of acquisition were provided.